The Sec61 translocon is a therapeutic vulnerability in multiple myelomaEMBO Molecular MedicineJanuary 11, 202210.15252/emmm.202114740Cited by 30SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis